FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015936114> ?p ?o ?g. }

• W2015936114 endingPage "40" @default.
• W2015936114 startingPage "32" @default.
• W2015936114 abstract "S-hyoscyamine (S-hyo) is a toxic tropane alkaloid from plants of the solanacea family, which is extracted for pharmaceutical purposes thereby undergoing racemization (atropine). Merely the S-hyo enantiomer acts as an antagonist of muscarinic receptors (MR). Nevertheless, racemic atropine is clinically administered in e.g. ophthalmology and for symptomatic therapy of acute poisoning with organophosphorus compounds (OPCs, e.g. pesticides, nerve agents). However, very limited data are available of comparative pharmacokinetics of S- and R-enantiomers in humans or other species. Therefore, we developed an enantioselective LC–ESI-MS/MS assay making use of rabbit serum containing atropinesterase (AtrE, EC 3.1.1.10) which is suitable for stereospecific hydrolysis of S-hyo into tropine and tropic acid while R-hyo is unaffected. For sample preparation plasma was incubated with human serum (not containing AtrE, procedure A) and with rabbit serum (procedure B). Afterwards, hyoscyamines were quantified by a validated previously published non-chiral LC–ESI-MS/MS method. Following procedure A the concentration of total hyo and following procedure B remaining R-hyo were determined. S-hyo was calculated by the difference between these concentrations. This assay design allowed reproducible, precise (RSD 2–9%), accurate (93–101%) and selective determination of total and individual hyoscyamines. Potential therapeutics for OPC poisoning (carbamates, oximes) and thiono-pesticides did not interfere with the assay whereas some oxon-pesticides inhibited S-hyo hydrolysis. A control experiment was designed allowing to be aware of such interferences thus avoiding the use of false results. To validate this assay, results were compared to those from a novel isocratic chiral LC–ESI-MS/MS method. Separation of S-hyo (tR 31.1 ± 0.2 min) and R-hyo (tR 33.4 ± 0.2 min) was achieved on α-glycoprotein (AGP) chiral stationary phase at 40 °C (selectivity factor α 1.07). Ammoniumformate (0.01 M, pH 8.0) with 3.75% (v/v) acetonitrile served as mobile phase (300 μL min−1). Hyoscyamines were detected in the positive multiple reaction monitor mode. The enantioselective assay was applied to the analysis of atropine degradation in diluted rabbit serum in vitro as well as to human in vivo plasma samples from a pesticide-poisoned patient treated with atropine." @default.
• W2015936114 created "2016-06-24" @default.
• W2015936114 creator A5046936730 @default.
• W2015936114 creator A5065057160 @default.
• W2015936114 creator A5072468811 @default.
• W2015936114 creator A5078195672 @default.
• W2015936114 date "2010-11-01" @default.
• W2015936114 modified "2023-10-07" @default.
• W2015936114 title "High-performance liquid-chromatographic tandem-mass spectrometric methods for atropinesterase-mediated enantioselective and chiral determination of R- and S-hyoscyamine in plasma" @default.
• W2015936114 cites W103696654 @default.
• W2015936114 cites W1565709800 @default.
• W2015936114 cites W1975065256 @default.
• W2015936114 cites W1984831910 @default.
• W2015936114 cites W1989849877 @default.
• W2015936114 cites W1995350161 @default.
• W2015936114 cites W1998974961 @default.
• W2015936114 cites W1999307383 @default.
• W2015936114 cites W1999721210 @default.
• W2015936114 cites W2011324379 @default.
• W2015936114 cites W2022955684 @default.
• W2015936114 cites W2027492500 @default.
• W2015936114 cites W2031197339 @default.
• W2015936114 cites W2031254665 @default.
• W2015936114 cites W2040103562 @default.
• W2015936114 cites W2042987972 @default.
• W2015936114 cites W2050883888 @default.
• W2015936114 cites W2060883036 @default.
• W2015936114 cites W2077356525 @default.
• W2015936114 cites W2078381100 @default.
• W2015936114 cites W2078599223 @default.
• W2015936114 cites W2080183399 @default.
• W2015936114 cites W2091764921 @default.
• W2015936114 cites W2092568202 @default.
• W2015936114 cites W2108197008 @default.
• W2015936114 cites W2119049639 @default.
• W2015936114 cites W2138057283 @default.
• W2015936114 cites W2170521826 @default.
• W2015936114 cites W2171545674 @default.
• W2015936114 doi "https://doi.org/10.1016/j.aca.2010.09.018" @default.
• W2015936114 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20969988" @default.
• W2015936114 hasPublicationYear "2010" @default.
• W2015936114 type Work @default.
• W2015936114 sameAs 2015936114 @default.
• W2015936114 citedByCount "31" @default.
• W2015936114 countsByYear W20159361142012 @default.
• W2015936114 countsByYear W20159361142013 @default.
• W2015936114 countsByYear W20159361142014 @default.
• W2015936114 countsByYear W20159361142015 @default.
• W2015936114 countsByYear W20159361142016 @default.
• W2015936114 countsByYear W20159361142017 @default.
• W2015936114 countsByYear W20159361142018 @default.
• W2015936114 countsByYear W20159361142022 @default.
• W2015936114 crossrefType "journal-article" @default.
• W2015936114 hasAuthorship W2015936114A5046936730 @default.
• W2015936114 hasAuthorship W2015936114A5065057160 @default.
• W2015936114 hasAuthorship W2015936114A5072468811 @default.
• W2015936114 hasAuthorship W2015936114A5078195672 @default.
• W2015936114 hasConcept C104317684 @default.
• W2015936114 hasConcept C146686406 @default.
• W2015936114 hasConcept C161790260 @default.
• W2015936114 hasConcept C185592680 @default.
• W2015936114 hasConcept C2775859210 @default.
• W2015936114 hasConcept C2777667214 @default.
• W2015936114 hasConcept C2778761015 @default.
• W2015936114 hasConcept C2780796293 @default.
• W2015936114 hasConcept C42219234 @default.
• W2015936114 hasConcept C43617362 @default.
• W2015936114 hasConcept C486523 @default.
• W2015936114 hasConcept C55493867 @default.
• W2015936114 hasConcept C71240020 @default.
• W2015936114 hasConcept C71924100 @default.
• W2015936114 hasConcept C98274493 @default.
• W2015936114 hasConceptScore W2015936114C104317684 @default.
• W2015936114 hasConceptScore W2015936114C146686406 @default.
• W2015936114 hasConceptScore W2015936114C161790260 @default.
• W2015936114 hasConceptScore W2015936114C185592680 @default.
• W2015936114 hasConceptScore W2015936114C2775859210 @default.
• W2015936114 hasConceptScore W2015936114C2777667214 @default.
• W2015936114 hasConceptScore W2015936114C2778761015 @default.
• W2015936114 hasConceptScore W2015936114C2780796293 @default.
• W2015936114 hasConceptScore W2015936114C42219234 @default.
• W2015936114 hasConceptScore W2015936114C43617362 @default.
• W2015936114 hasConceptScore W2015936114C486523 @default.
• W2015936114 hasConceptScore W2015936114C55493867 @default.
• W2015936114 hasConceptScore W2015936114C71240020 @default.
• W2015936114 hasConceptScore W2015936114C71924100 @default.
• W2015936114 hasConceptScore W2015936114C98274493 @default.
• W2015936114 hasIssue "1-2" @default.
• W2015936114 hasLocation W20159361141 @default.
• W2015936114 hasLocation W20159361142 @default.
• W2015936114 hasOpenAccess W2015936114 @default.
• W2015936114 hasPrimaryLocation W20159361141 @default.
• W2015936114 hasRelatedWork W1987597807 @default.
• W2015936114 hasRelatedWork W2001911836 @default.
• W2015936114 hasRelatedWork W2026709745 @default.
• W2015936114 hasRelatedWork W2036248792 @default.
• W2015936114 hasRelatedWork W2041612527 @default.
• W2015936114 hasRelatedWork W2054150937 @default.

• next